API | copper undecylenate

copper undecylenate Report issue

Small molecule Experimental

Active Ingredient History

Copper undecylenate was used for the therapy of cutaneous dermatomycoses combined with a wetting agent and dissolved in a fat-solvent base. Undecylenic acid inhibits the morphogenesis of Candida albicans to its invasive fungal form and inhibits conversion of unicellular yeast to their hyphal form. ^NCATS

Chemistry

SMILES: [Cu++].[O-]C(=O)CCCCCCCCC=C.[O-]C(=O)CCCCCCCCC=C
InChIKey: AJPUPGDBTGSBCZ-UHFFFAOYSA-L
Mol. Mass: 430.081
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

Indications (1)

Approved Indications (1)

Dermatomycoses

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue